Ultrasound for Liver Cancer: Detection, Screening, and Monitoring

At Independent Physicians Medical Center (IPMC) in Northeast Philadelphia, we offer liver ultrasound imaging to support early detection and ongoing monitoring of liver conditions.

How Is Ultrasound Used for Liver Cancer?

Liver ultrasound plays several important roles in liver cancer care:

Screening. Major medical guidelines recommend that patients at high risk for hepatocellular carcinoma (HCC) — the most common type of primary liver cancer — undergo ultrasound screening every 6 months. High-risk patients include those with cirrhosis from any cause (hepatitis B, hepatitis C, alcohol, non-alcoholic steatohepatitis/NASH), chronic hepatitis B carriers (even without cirrhosis, depending on risk factors), and patients with other risk factors identified by their hepatologist.

Detection. Ultrasound can identify liver masses, nodules, and areas of abnormal echogenicity that may represent cancer. It can detect tumors as small as 1-2 cm in experienced hands, though sensitivity varies depending on the patient’s body habitus and the severity of underlying liver disease.

Characterization. While ultrasound can identify suspicious masses, it generally cannot definitively distinguish between benign and malignant lesions. When a suspicious mass is found, further imaging with contrast-enhanced CT or MRI is typically recommended for definitive characterization. This multi-step approach is standard practice.

Monitoring. Ultrasound is used to track known liver lesions over time, monitor patients after liver cancer treatment (surgery, ablation, transplant), and assess for recurrence.

Doppler assessment. Color and spectral Doppler evaluate blood flow in the portal vein and hepatic veins, which is important for detecting portal vein thrombosis (a potential complication of advanced liver disease and HCC) and assessing vascular invasion by tumor.

Limitations of Ultrasound for Liver Cancer

While ultrasound is valuable, it does have limitations:

Sensitivity for detecting small HCC in the setting of cirrhosis ranges from about 60-80%. Cirrhotic livers are nodular and heterogeneous, which makes it harder to distinguish a small cancer from the irregular background texture. Larger body habitus can reduce image quality. Not all liver masses found on ultrasound are cancer — benign findings are common.

For these reasons, ultrasound is used as a screening tool, and any suspicious finding is followed up with CT or MRI for definitive evaluation. Some centers have begun exploring contrast-enhanced ultrasound (CEUS) as a way to improve liver mass characterization without radiation.

What to Expect During the Exam

You will likely be asked to fast for several hours before the exam to reduce bowel gas and optimize image quality. You’ll lie on an exam table while the sonographer applies gel and scans your upper abdomen, focusing on the liver. The exam typically takes 20 to 30 minutes. Both lobes of the liver are systematically evaluated, along with the portal vein, hepatic veins, and surrounding structures.

The exam is painless. A board-certified radiologist will review the images and send a report to your doctor. If this is a screening ultrasound, your doctor will let you know when your next screening is due (typically in 6 months).